搜尋





搜尋





市場行情
/
股票
/
beam
/

Beam Therapeutics Inc

BEAM

添加自選

25.810USD

+0.290+1.14%

交易中（美東）報價延遲15分鐘

2.62B總市值

虧損本益比TTM

Beam Therapeutics Inc

25.810

+0.290+1.14%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

BEAM 利潤表

您可以在這裡找到Beam Therapeutics Inc的年度或季度收入報告，以深入了解Beam Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

營業總收入

324.87%31.74M

279.52%114.11M

-32.03%9.70M

-28.08%8.47M

0.81%7.47M

-90.49%30.07M

-17.01%14.27M

-41.48%11.77M

-69.39%7.41M

1478.04%316.19M

8.82%17.19M

20.80%20.12M

187.10%24.21M

-60.76%20.04M

1970.64%15.80M

277433.33%16.65M

140433.33%8.43M

851050.00%51.07M

12616.67%763.00K

0.00%6.00K

--6.00K

--0.00

----

--0.00

營業收入

324.87%31.74M

279.52%114.11M

-32.03%9.70M

-28.08%8.47M

0.81%7.47M

-90.49%30.07M

-17.01%14.27M

-41.48%11.77M

-69.39%7.41M

1478.04%316.19M

8.82%17.19M

20.80%20.12M

187.10%24.21M

-60.76%20.04M

1970.64%15.80M

277433.33%16.65M

140433.33%8.43M

851050.00%51.07M

12616.67%763.00K

0.00%6.00K

--6.00K

--0.00

----

--0.00

營業費用

9.62%138.95M

1.11%131.55M

13.03%136.51M

10.24%128.62M

13.64%126.76M

-29.03%130.10M

-3.74%120.77M

-4.58%116.67M

-9.42%111.54M

68.16%183.33M

17.14%125.46M

23.98%122.26M

45.45%123.14M

-4.83%109.02M

52.14%107.10M

67.21%98.62M

-57.75%84.66M

180.73%114.55M

88.60%70.40M

124.34%58.98M

606.53%200.38M

54.70%40.80M

107.03%37.33M

48.90%26.29M

116.36%28.36M

94.48%26.38M

42.10%18.03M

--17.66M

--13.11M

--13.56M

--12.69M

研發費用

5.78%104.52M

-2.14%99.28M

16.46%109.77M

16.91%101.76M

16.50%98.82M

-27.58%101.44M

-5.79%94.26M

-10.83%87.04M

-14.88%84.82M

62.24%140.08M

17.31%100.05M

30.92%97.61M

52.34%99.65M

-10.79%86.34M

56.14%85.29M

63.58%74.56M

-65.59%65.41M

198.24%96.78M

83.15%54.62M

135.49%45.58M

782.20%190.11M

60.51%32.45M

137.78%29.82M

52.63%19.35M

134.76%21.55M

105.21%20.22M

27.29%12.54M

--12.68M

--9.18M

--9.85M

折舊攤銷及損耗

1.39%5.61M

4.13%5.67M

1.55%5.56M

-0.68%5.54M

1.79%5.53M

1.51%5.44M

5.55%5.47M

15.78%5.58M

16.87%5.43M

35.95%5.36M

49.35%5.19M

40.90%4.82M

40.31%4.65M

49.73%3.94M

98.46%3.47M

104.79%3.42M

136.91%3.31M

107.08%2.63M

43.68%1.75M

45.76%1.67M

27.09%1.40M

26.95%1.27M

34.14%1.22M

33.45%1.15M

49.66%1.10M

87.99%1.00M

1318.75%908.00K

--858.00K

--735.00K

--533.00K

--64.00K

營業利潤

10.12%-107.22M

82.56%-17.45M

-19.07%-126.81M

-14.54%-120.15M

-14.55%-119.29M

-175.30%-100.04M

1.63%-106.50M

-2.69%-104.89M

-5.26%-104.13M

249.30%132.86M

-18.58%-108.27M

-24.62%-102.15M

-29.78%-98.93M

-40.17%-88.98M

-31.12%-91.30M

-38.99%-81.97M

61.96%-76.22M

-55.60%-63.48M

-86.58%-69.63M

-124.36%-58.97M

-606.66%-200.37M

-54.71%-40.80M

-107.06%-37.32M

-48.92%-26.29M

-116.32%-28.36M

-94.43%-26.37M

-42.06%-18.02M

---17.65M

---13.11M

---13.56M

---12.69M

淨非營業利息收入（費用）

利息收入

----

70.52%1.02M

-93.06%35.00K

-75.47%169.00K

-3.52%767.00K

19.88%597.00K

132.26%504.00K

818.67%689.00K

--795.00K

--498.00K

--217.00K

--75.00K

利息費用

----

16.81%139.00K

105.88%140.00K

--148.00K

--100.00K

--119.00K

--68.00K

----

出售證券收益

----

--255.15M

----

--139.00K

--140.00K

--148.00K

--100.00K

----

股權收益

100.77%16.00K

-205.41%-3.33M

339.20%4.94M

158.20%4.42M

37.94%-2.08M

-50.97%-1.09M

81.61%-2.06M

-223.39%-7.59M

73.80%-3.35M

-103.35%-722.00K

-207.57%-11.22M

249.08%6.15M

-66.52%-12.80M

198.26%21.58M

313.23%10.43M

-115.98%-4.12M

---7.69M

---21.96M

---4.89M

--25.81M

----

特殊收入（費用）

34.98%3.01M

-361.29%-715.00K

-674.01%-1.76M

-84.63%1.12M

173.62%2.23M

-318.92%-155.00K

-102.12%-227.00K

472.70%7.28M

-157.18%-3.03M

-100.16%-37.00K

285.32%10.70M

-89.48%1.27M

-62.25%5.30M

8.53%22.45M

-112.45%-5.78M

128.07%12.08M

737.28%14.05M

137.81%20.68M

1618.48%46.40M

-394.72%-43.04M

18.33%-2.21M

-2938.89%-54.70M

268.75%2.70M

-770.00%-8.70M

-170.00%-2.70M

70.97%-1.80M

68.22%-1.60M

---1.00M

---6.20M

---5.03M

其他非經營性收入（費用）

--94.32M

----

98.87%-64.00K

100.00%-2.00K

---5.00K

----

---5.65M

---53.50M

稅前利潤

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.39%-102.29M

-10.74%-109.27M

-162.67%-90.35M

-0.60%-96.67M

-9.95%-91.01M

-2.29%-98.67M

485.99%144.16M

-17.66%-96.09M

-15.05%-82.78M

-39.36%-96.46M

42.28%-37.35M

-190.44%-81.67M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-561.76%-201.56M

-242.78%-95.46M

-81.28%-34.45M

-91.58%-34.22M

-123.79%-30.46M

-10.54%-27.85M

73.29%-19.00M

---17.86M

---13.61M

---25.19M

---71.15M

所得稅

--0.00

-100.00%0.00

----

-100.00%0.00

--0.00

--39.00K

----

36.60%1.37M

-100.00%0.00

----

--1.00M

--2.41M

----

除稅後的權益收益

----

--0.00

----

--0.00

100.00%0.00

----

--0.00

---25.50M

----

除稅後利潤

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.34%-102.29M

-10.74%-109.27M

-163.27%-90.35M

-0.60%-96.67M

-10.00%-91.05M

-2.29%-98.67M

472.36%142.80M

-14.29%-96.09M

-15.05%-82.78M

-39.36%-96.46M

40.73%-38.35M

-199.01%-84.08M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-561.76%-201.56M

-242.78%-95.46M

-81.28%-34.45M

-91.58%-34.22M

-123.79%-30.46M

-10.54%-27.85M

73.29%-19.00M

---17.86M

---13.61M

---25.19M

---71.15M

持續經營利潤

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.34%-102.29M

-10.74%-109.27M

-163.27%-90.35M

-0.60%-96.67M

-10.00%-91.05M

-2.29%-98.67M

472.36%142.80M

12.31%-96.09M

-15.05%-82.78M

-39.36%-96.46M

40.73%-38.35M

-289.70%-109.58M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-561.76%-201.56M

-242.78%-95.46M

-81.28%-34.45M

-91.58%-34.22M

-123.79%-30.46M

-10.54%-27.85M

73.29%-19.00M

---17.86M

---13.61M

---25.19M

---71.15M

歸屬少數股東的淨利潤

----

--0.00

100.00%0.00

--0.00

----

--0.00

---1.35M

歸属于母公司的淨利潤

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.34%-102.29M

-10.74%-109.27M

-163.27%-90.35M

-0.60%-96.67M

-10.00%-91.05M

-2.29%-98.67M

472.36%142.80M

12.31%-96.09M

-15.05%-82.78M

-39.36%-96.46M

40.73%-38.35M

-289.70%-109.58M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-535.13%-201.56M

-206.83%-95.46M

-54.72%-34.45M

-62.27%-34.22M

-91.49%-31.73M

-18.29%-31.11M

68.37%-22.27M

---21.09M

---16.57M

---26.30M

---70.41M

優先股派息

----

--0.00

----

--0.00

----

-100.00%0.00

-56.90%1.28M

194.23%3.26M

439.17%3.26M

--3.23M

--2.96M

--1.11M

--605.00K

歸屬普通股東的淨利潤

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.34%-102.29M

-10.74%-109.27M

-163.27%-90.35M

-0.60%-96.67M

-10.00%-91.05M

-2.29%-98.67M

472.36%142.80M

12.31%-96.09M

-15.05%-82.78M

-39.36%-96.46M

40.73%-38.35M

-289.70%-109.58M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-535.13%-201.56M

-206.83%-95.46M

-54.72%-34.45M

-62.27%-34.22M

-91.49%-31.73M

-18.29%-31.11M

68.37%-22.27M

---21.09M

---16.57M

---26.30M

---70.41M

基本每股收益

26.46%-0.91

317.59%2.37

6.31%-1.10

9.33%-1.00

-2.84%-1.24

-161.80%-1.09

3.53%-1.17

-2.01%-1.11

9.51%-1.21

425.81%1.77

21.94%-1.22

-5.82%-1.08

-32.48%-1.33

43.04%-0.54

-267.73%-1.56

16.39%-1.02

69.91%-1.01

43.59%-0.95

38.41%-0.42

-77.06%-1.23

-224.11%-3.35

-145.64%-1.69

-40.01%-0.69

-48.79%-0.69

-182.48%-1.03

-18.29%-0.69

68.37%-0.49

---0.47

---0.37

---0.58

---1.55

稀釋每股收益

26.46%-0.91

317.59%2.37

6.31%-1.10

9.33%-1.00

-2.84%-1.24

-161.80%-1.09

3.53%-1.17

-2.01%-1.11

9.51%-1.21

425.81%1.77

21.94%-1.22

-5.82%-1.08

-32.48%-1.33

43.04%-0.54

-267.73%-1.56

16.39%-1.02

69.91%-1.01

43.59%-0.95

38.41%-0.42

-77.06%-1.23

-224.11%-3.35

-145.64%-1.69

-40.01%-0.69

-48.79%-0.69

-182.48%-1.03

-18.29%-0.69

68.37%-0.49

---0.47

---0.37

---0.58

---1.55

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Beam Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 BEAM 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Beam Therapeutics Inc 財年末的營收是多少？



Beam Therapeutics Inc 2025 財年營收為 139.74M，高於上一財年的 63.52M。

Beam Therapeutics Inc 最近一個季度的營收是多少？



Beam Therapeutics Inc 最近一個季度的營收為 31.74M，同比增長 324.87%。

Beam Therapeutics Inc 全年的淨利潤是多少？



Beam Therapeutics Inc 2025 財年淨利潤為 -79.99M。

Beam Therapeutics Inc 上一季度的淨利潤是多少？



Beam Therapeutics Inc 最近一個季度的淨利潤為 -94.32M。

Beam Therapeutics Inc 年度營業利潤是多少？



Beam Therapeutics Inc 2025 財年的營業利潤為 -383.69M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。